SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Who’s Going to SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
419 cancer centers, universities and companies, with 1,293 speakers and abstract presenters and 20 supporters, at the Society for Neuro-Oncology (SNO) 2026 Annual Meeting, a ~3,000-person, mostly clinical & academic meeting of neuro-oncologists, neurosurgeons and brain tumor researchers. As of Nov 12, 2026.
| Organization | SNO 2026 Attendance |
|---|---|
Mayo Clinic Rochester, MN | |
A nonprofit academic medical center with cancer programs and neuro-oncology care and research across its campuses. | Session Thu Nov 12 8:30–8:40am Session Thu Nov 12 8:40–9:55am Session Thu Nov 12 10:10–11:45am Session Thu Nov 12 12:35–2:10pm Talk Thu Nov 12 12:35–2:10pm Talk Thu Nov 12 2–3:30pm Talk Thu Nov 12 2–3:30pm Session Thu Nov 12 2–3:30pm Session Thu Nov 12 4:25–4:30pm Talk Thu Nov 12 4:30–5:35pm Session Thu Nov 12 4:30–5:35pm Session Fri Nov 13 8:30–10am Plenary Fri Nov 13 8:30–10am Session Fri Nov 13 10:15–11:15am Session Fri Nov 13 10:15–11:15am Talk Fri Nov 13 10:22–10:29am Talk Fri Nov 13 10:54–10:59am Talk Fri Nov 13 10:59–11:04am Session Fri Nov 13 11:30am–12:30pm Talk Fri Nov 13 11:33–11:36am Session Fri Nov 13 12:45–2:15pm Session Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 3:14–3:19pm Session Fri Nov 13 3:45–4:45pm Session Fri Nov 13 3:45–4:45pm Talk Fri Nov 13 3:45–4:45pm Session Fri Nov 13 5–6pm Talk Fri Nov 13 5–6pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Session Sat Nov 14 8:30–10am Plenary Sat Nov 14 8:30–10am Session Sat Nov 14 10:15–11:15am Session Sat Nov 14 10:15–11:15am Talk Sat Nov 14 10:15–11:15am Talk Sat Nov 14 10:15–11:15am Talk Sat Nov 14 11:42–11:45am Talk Sat Nov 14 11:45–11:48am Talk Sat Nov 14 11:45–11:48am Talk Sat Nov 14 11:54–11:57am Talk Sat Nov 14 12:18–12:21pm Talk Sat Nov 14 12:21–12:24pm Session Sat Nov 14 12:45–2:15pm Session Sat Nov 14 2:30–3:30pm Talk Sat Nov 14 3:09–3:14pm Talk Sat Nov 14 4:24–4:29pm Session Sat Nov 14 5–6pm Session Sun Nov 15 8:30–9:30am Talk Sun Nov 15 8:30–9:30am Talk Sun Nov 15 9:45–10:45am Session Sun Nov 15 11am–12pm Talk Sun Nov 15 11am–12pm Talk Sun Nov 15 11:21–11:28am |
Find buyers from organizations at SNO 2026
Tell us what you sell and we’ll find the people at these organizations most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where was SNO 2026?
31st Annual Meeting & Education Day of the Society for Neuro-Oncology ran November 12–15, 2026, at the Pennsylvania Convention Center in Philadelphia, PA.
What conference is this?
SNO 2026 is the 31st Annual Meeting and Education Day of the Society for Neuro-Oncology, held November 12–15, 2026 at the Pennsylvania Convention Center in Philadelphia, with a review course, a clinical trials workshop and early-career sessions on November 11. It brings together the clinicians and scientists who treat and study brain and spine tumors: neuro-oncologists, neurosurgeons, radiation oncologists, neuropathologists, neuroradiologists and laboratory researchers.
What is in this guide?
Every organization we can place at SNO 2026: the institutions of its 1,293 speakers, moderators and presenting authors (1,219 abstracts presented as talks or posters, and 318 invited talks and sessions in the public program), the companies behind its industry-supported sessions and the 20 supporters on the meeting’s supporters page — 419 organizations in one list. An abstract is listed under its presenting author’s institution only. People appear as a count, never by name, and abstract text is not shown.
How are organizations typed?
By the role an organization plays in brain tumor care and research: drug developers (large pharma and biotech), diagnostics, device and service companies, hospitals and cancer centers, universities and research institutes, and government agencies, foundations, patient groups and societies. An abstract’s topic is the abstract category the organizers filed it under; a session’s is its track.
Does SNO 2026 have an exhibitor list?
The organizers publish no exhibitor list or booth numbers. The meeting’s supporters page lists its supporters by level (Platinum, Supporter and Contributor), shown here as a badge on each organization’s row, and the program names the companies behind each industry-supported session.
How current is it?
Pulled from the public SNO 2026 program and the meeting’s supporters page on November 12, 2026, the meeting’s first day. Changes to the program after that date are not reflected.
Browse SNO 2026 by
- Tumor biology: signaling, metabolism, stem cells and the tumor microenvironment 106
- Cancer neuroscience: how neurons and brain tumors interact 54
- Immunobiology, immunotherapy and cell therapies 64
- Experimental therapeutics, drug discovery and resistance, drug delivery and tumor models 105
- Clinical trials, trial design and trials in progress 99
- Molecular pathology, tumor classification and (epi)genomics 102
- Biomarkers and liquid biopsy 53
- Neuroimaging, PET and response assessment 62
- Neurosurgery and surgical therapies 41
- Radiotherapy, radiobiology and radiopharmaceuticals 49
- Pediatric and adolescent and young adult (AYA) brain tumors 55
- Brain and leptomeningeal metastases 27
- Rare CNS tumors and tumor predisposition syndromes 34
- CNS lymphoma and neurohematology 13
- Survivorship, quality of life, cognition, neurologic complications and palliative care 105
- Health disparities, epidemiology and quality improvement 58
Organizations with their own page
43 organizations — every exhibitor and every organization with 2 or more presentations.
- BrainSpec
- Brigham and Women's Hospital
- Brown University
- Case Western Reserve University
- Children's Hospital Los Angeles
- Children's Hospital of Philadelphia
- Children's National Hospital
- Cleveland Clinic
- Columbia University Irving Medical Center
- Dana-Farber Cancer Institute
- Duke University
- Duke University Health System
- Edison Oncology
- Emory University
- Henry Ford Health
- Jazz Pharmaceuticals
- Johns Hopkins University
- Mass General Brigham
- Massachusetts General Hospital
- Mayo Clinic
- MD Anderson Cancer Center
- Memorial Sloan Kettering Cancer Center
- Miami Cancer Institute
- National Cancer Institute
- Northwestern University
- Novocure
- NYU Langone
- Oxford University Press
- Servier
- St. Jude Children's Research Hospital
- Stanford University
- Sunnybrook Health Sciences Centre
- University of Alabama at Birmingham
- University of California, Los Angeles
- University of California, San Francisco (UCSF)
- University of Florida
- University of Miami
- University of Michigan
- University of Pennsylvania
- University of Toronto
- Virginia Commonwealth University
- Washington University in St. Louis
- Yale University
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction